By SmokerBar Editorial Team

In 2026, the nicotine landscape looks dramatically different from just five years ago. Walk into any convenience store, scroll through social media, or simply listen to conversations among adult nicotine users, and you will hear one name consistently rising to the top: ZYN.

ZYN nicotine pouches—small, discreet, tobacco‑free pouches placed between the gum and cheek—have exploded in popularity, transforming from a niche product into a cultural phenomenon. In 2025 alone, ZYN shipped 794 million cans globally, capturing an astonishing 66% of the U.S. oral nicotine market. The brand now reaches 55 countries worldwide, with shipment volumes climbing 36.6% year‑over‑year. For Philip Morris International (PMI), smoke‑free products (including ZYN and IQOS) now account for 41.5% of total net revenues, up nearly three percentage points from the previous year.

But with this meteoric rise comes intense scrutiny. In this 2026 guide, we will explore why ZYN has become so popular, how it compares to other nicotine products, who is using it, and what the future holds under ongoing FDA review.

What Are ZYN Nicotine Pouches?

Before diving into the popularity surge, let us clarify what ZYN actually is. ZYN is a brand of nicotine pouch—a small, white, teabag‑like sachet containing nicotine, plant‑based fibers, flavorings, sweeteners, and pH adjusters. Unlike traditional tobacco products, ZYN contains no tobacco leaf. Unlike vaping, it produces no vapor. Unlike cigarettes, it involves no combustion.

Users place a pouch between the upper lip and gum, where nicotine is absorbed through the oral mucosa into the bloodstream. The experience is discreet, spit‑free, and odorless—allowing adult nicotine users to satisfy cravings without smoke, vapor, or the social stigma associated with traditional tobacco.

ZYN is available in 3 mg and 6 mg strengths (in the U.S.) and a wide variety of flavors, including Cool Mint, Spearmint, Wintergreen, Peppermint, Citrus, Coffee, Cinnamon, and Menthol, as well as Chill (cooling sensation) and Smooth (flavorless) varieties.

The Numbers Behind the Boom: ZYN by the Numbers (2026)

The growth statistics are staggering. Between 2018 and 2023, the number of ZYN cans shipped in the U.S. rose from 6 million to 334 million. In 2025, that figure more than doubled to 794 million cans, representing a 37% increase in U.S. shipments alone. According to PMI’s 2025 earnings report, ZYN shipment volumes climbed 36.6% year‑over‑year, with net revenues exceeding $40 billion and smoke‑free products leading the charge.

Nicotine pouch sales in the U.S. surged by 250.8% between January 2023 and August 2025, according to CDC Foundation analysis of sales data. The U.S. has now become the world’s largest nicotine pouch market, and ZYN commands the dominant share.

By the end of 2023, ZYN accounted for 72.8% of the nicotine pouch market, according to PMI. By 2025, that figure had shifted slightly due to competition from brands like Velo (owned by British American Tobacco) and On! (owned by Altria), but ZYN remains the clear leader—still holding roughly 70% of the U.S. nicotine pouch market.

Why Is ZYN So Popular? The Drivers of Growth

Several factors have contributed to ZYN’s explosive rise.

1. A Smoke‑Free, Discreet Alternative

For adult smokers who want to reduce harm but cannot or will not quit nicotine, ZYN offers a compelling alternative. It eliminates combustion, smoke, and secondhand exposure—the primary vectors for smoking‑related disease. The FDA’s January 2025 PMTA authorization confirmed that ZYN products present “greater benefits to population health than risks” for adult smokers who switch completely.

2. Flavor Variety

Unlike traditional cigarettes (mostly tobacco or menthol), ZYN offers a wide palette of appealing flavors—mint, wintergreen, citrus, coffee, cinnamon—making the experience more enjoyable and less monotonous. While flavored tobacco products have faced restrictions in jurisdictions like California, ZYN’s flavor lineup remains a key driver of consumer appeal.

3. Social Media and the “Zynfluencer” Effect

Perhaps the most unique driver of ZYN’s popularity has been its organic rise on social media. A 2026 study from Truth Initiative found a reciprocal relationship between ZYN sales and viral content on TikTok. Researchers analyzed thousands of pouch‑related videos on TikTok and found that a viral spike in content was followed by a significant acceleration in market growth—sales increased by more than 12 million units, rising to over 20 million in the next month.

The prevalence of pouch‑related videos on youth‑centric social media platforms, featuring unpaid “Zynfluencers,” has spread the message that pouches are cool, harmless, and socially acceptable. This evolution mirrors the pattern observed a decade ago with JUUL, when youth‑targeted marketing and culture led to a boom in youth e‑cigarette use. A content analysis of ZYN‑related TikTok posts found that they “often featured pro‑tobacco themes, such as humor and product use, while rarely mentioning anti‑tobacco themes such as cessation”.

4. Regulatory Approval and Legitimacy

ZYN received PMTA authorization from the FDA in January 2025—the first nicotine pouch brand to do so—covering 20 products in 10 flavors across 3 mg and 6 mg strengths. This authorization provided a stamp of regulatory legitimacy, distinguishing ZYN from unregulated competitors and reinforcing consumer confidence.

Youth and Young Adult Use: The Public Health Concern

With popularity comes scrutiny, and ZYN’s rise among younger demographics has drawn significant concern from public health officials.

The National Youth Tobacco Survey (NYTS) found that nicotine pouches were the fourth most used tobacco product among youth in 2023 (after e‑cigarettes, combustible cigarettes, and cigars). While overall youth use remains lower than vaping, the trend line is alarming. A 2025 study in JAMA reported that nicotine pouch use among adolescents had surged more than 300% over two years.

According to the TEEN+ Study (a nationally representative study of over 10,000 youth and young adults), nicotine pouch use nearly quadrupled between 2022 and 2025. Among the key findings:

• 84.3% of youth and young adults who used pouches in the past month reported using ZYN

• Nearly two in five youth pouch users under 21 used them more than five days per month

• Most youth pouch users also used at least one other tobacco product (73% smoked cigarettes; 49% vaped)

• Pouches sold in mint, wintergreen, menthol, citrus, and fruit flavors were most commonly used

The CDC Foundation notes that nicotine use during adolescence can harm the parts of the brain that control attention, learning, mood, and impulse control. Nicotine pouches are often marketed as a “cleaner” or “safer” alternative, but they still contain highly addictive nicotine and are not risk‑free—especially for developing brains.

ZYN commands nearly 68.7% of the youth market, supported by social media campaigns and influencer endorsement. The FDA has also issued warning letters to numerous tobacco retailers for selling ZYN to underage decoys, and a 2025 study in Tobacco Control noted that variety of flavors, marketing messages of social comfort, and the ability to use products anywhere were primary drivers of desire to use nicotine pouches among those under 21.

FDA Regulation: PMTA, MRTP, and the Path Forward

ZYN’s regulatory journey is complex and ongoing, with significant implications for its future marketing and positioning.

PMTA Authorization (January 2025)

On January 17, 2025, the FDA authorized the marketing of 20 ZYN nicotine pouch products through the Premarket Tobacco Product Application (PMTA) pathway—the first time nicotine pouch products have ever received PMTA authorization. The FDA determined that these products contain “substantially lower levels of harmful ingredients compared with combustible cigarettes and most smokeless tobacco products,” and that a “substantial proportion” of adult smokers completely switched to ZYN in studies.

However, this authorization only permits ZYN to be sold—it does not allow the company to make reduced‑risk claims in marketing materials.

MRTP Application (Under Review)

In 2025, Swedish Match (ZYN’s manufacturer, now owned by PMI) submitted Modified Risk Tobacco Product (MRTP) applications for the same 20 ZYN products. If granted, ZYN would be permitted to market itself with a specific health claim: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis”.

On January 22, 2026, the FDA’s Tobacco Products Scientific Advisory Committee (TPSAC) held a virtual meeting to review the MRTP applications. The committee examined evidence on relative health risks, consumer understanding of the proposed claim, and potential public health impact.

During the meeting, the FDA stated that “the evidence suggests the proposed modified risk claim is scientifically accurate.” However, concerns were raised about the lack of long‑term epidemiological data specific to nicotine pouch users and the potential for the claim to be misunderstood by consumers.

The FDA has not yet issued a final decision on the MRTP applications. If granted, ZYN would gain a powerful marketing advantage over competitors. If denied, PMI’s stock—which has surged 29.7% over the past year on anticipation of approval—could face sharp reversals.

What About Other Brands?

Velo (BAT) and On! (Altria) also submitted PMTAs in 2020 and remain on the market pending final FDA decisions. However, ZYN is currently the only nicotine pouch brand with FDA PMTA authorization, giving it a significant competitive edge.

The Cooling Sensation Question

One regulatory nuance involves ZYN Chill, which uses the chemical WS-3 to impart a cooling sensation without mint flavor. Whether products that use WS‑3 are considered “flavored” under state laws like California’s SB 793 is currently being litigated (see R.J. Reynolds v. Bonta). The resolution of this case may have implications for the legality of products like ZYN Chill in flavor‑restricted jurisdictions.

Flavor Bans and State Regulations

ZYN’s flavored products have faced increasing restrictions at the state and local level. California’s SB 793 prohibits the sale of most flavored tobacco products, including flavored nicotine pouches. Under the law, all of ZYN’s flavored products—wintergreen, spearmint, cool mint, peppermint, cinnamon, coffee, and citrus—are prohibited for sale as flavored products. Only ZYN Smooth (flavorless) is permitted.

Massachusetts and several other jurisdictions have enacted similar flavor bans. Sales data shows that in states with flavor restrictions, nicotine pouch sales are dominated by “smooth/original” products (likely containing sweeteners) or those with cooling sensations (where not prohibited). In states without restrictions, mint and other flavors dominate.

Local jurisdictions seeking to regulate ZYN can adopt model definitions for “tobacco product” and “flavored tobacco product” that explicitly capture both taste/smell flavors and cooling/numbing sensations. Model language includes terms like “cool,” “chill,” “ice,” “fresh,” “arctic,” or “frost” as presumptive evidence of a flavored product.

ZYN vs. Snus vs. Other Nicotine Pouches

ZYN differs from traditional snus (like General or Siberia) in that it contains no commercial tobacco leaves. Instead, ZYN uses a powdered form of nicotine salt derived from tobacco leaves mixed with fillers. Snus contains moist tobacco leaf and is typically placed under the upper lip for longer periods.

Other competing nicotine pouch brands include:

• On! (owned by Altria) – strengths from 1.5 mg to 8 mg

• Velo (owned by British American Tobacco) – strengths from 2 mg to 7 mg, and the fastest‑growing competitor

• Lucy – a newer entrant

Despite competition, ZYN’s first‑mover advantage, flavor variety, and FDA authorization have solidified its market dominance. In 2025, BAT’s Velo captured two‑thirds of category growth, intensifying competition, but ZYN’s lead remains substantial.

The Dual Use Phenomenon

A significant public health concern is dual use—using nicotine pouches in combination with other tobacco products. The TEEN+ Study found that 73% of youth and young adult pouch users also smoked cigarettes, and 49% also vaped. Dual use may not reduce harm if users continue smoking or vaping alongside pouch use.

For adult smokers who switch completely to ZYN, the harm reduction benefits are clear. But for those who simply add ZYN to an existing smoking or vaping habit, the health benefits are diminished—and the risk of nicotine dependence increases.

What Does the Future Hold for ZYN?

Several key developments will shape ZYN’s trajectory in 2026 and beyond:

1. MRTP Decision

The FDA’s final decision on ZYN’s MRTP application will determine whether the brand can market itself with reduced‑risk claims. An approval would be a major victory for harm reduction advocates but could also be challenged by public health groups concerned about youth uptake.

2. Increasing Competition

BAT’s Velo captured two‑thirds of nicotine pouch growth in 2025, indicating that ZYN’s dominance is not guaranteed. Velo, On!, and other brands are investing heavily in marketing and distribution, potentially eroding ZYN’s market share over time.

3. Flavor Restrictions

More states may follow California and Massachusetts in banning flavored nicotine pouches. ZYN’s flavor lineup—a key driver of its appeal—could be significantly impacted by such restrictions. The litigation over cooling sensations (WS‑3) will also shape the regulatory landscape.

4. Youth Use Prevention

As youth pouch use continues to rise, the FDA and state attorneys general may impose stricter marketing restrictions, age verification requirements, or penalties for retailers selling to minors. PMI emphasizes that it uses age‑gating on ZYN’s website and states that its products are only intended for people at least 21 years old, but enforcement remains challenging.

5. Global Expansion

ZYN is now available in 55 countries, with particularly strong growth in Europe and emerging markets. As global regulatory frameworks for nicotine pouches evolve—some countries classify them as tobacco products, others as pharmaceuticals, and others as regular consumer goods—ZYN’s international expansion will face varying challenges and opportunities.

6. Synthetic Nicotine

Some competitors use synthetic nicotine (not derived from tobacco), which may fall outside certain tobacco regulations. ZYN currently uses nicotine derived from commercial tobacco and has not shifted to synthetic alternatives. This distinction could become strategically important if tobacco‑derived products face stricter regulation.

Final Thoughts: A Phenomenon at a Crossroads

ZYN nicotine pouches have achieved something remarkable: they have become a mainstream consumer product, a social media phenomenon, and a genuine harm reduction tool for adult smokers—all within a few years.

The numbers speak for themselves: 794 million cans shipped in 2025, 66% U.S. market share, 55 countries, 36.6% annual growth. For adult smokers who have switched completely, ZYN offers a dramatically less harmful alternative to combustible cigarettes.

But with success comes scrutiny. The surge in youth use—nearly quadrupling between 2022 and 2025, with 84% of young users choosing ZYN—has alarmed public health officials and regulators. The viral “Zynfluencer” culture on TikTok mirrors the playbook that fueled the youth vaping epidemic a decade ago.

As the FDA deliberates on MRTP status and states consider stricter flavor bans, ZYN stands at a crossroads. Will it continue to grow as a harm reduction tool for adult smokers? Or will it become the next flashpoint in the youth nicotine debate?

For adult nicotine users, the responsible choice is clear: use ZYN as intended—as a complete substitute for cigarettes, not an addition to them. Keep pouches out of the reach of children. And stay informed as the regulatory landscape evolves in 2026 and beyond.

At SmokerBar, we carry authentic ZYN nicotine pouches in all popular flavors and strengths, along with alternatives like Velo, On!, White Fox, and more. All products are for adult nicotine users aged 18+ or 21+ depending on local laws.

Browse our ZYN collection today—and stay ahead of the trend.

Disclaimer: This product contains nicotine. Nicotine is an addictive chemical. For adult nicotine users aged 18+ only. Keep out of reach of children and pets. This article is for informational purposes and does not constitute legal or medical advice. Always check local regulations before purchasing or using nicotine products.